Illinois Court Rules for Defendant in Prenatal Monitoring Patent Dispute
Was möchten Sie als Nächstes tun?
Wählen Sie Ihren Weg entsprechend Ihren aktuellen Bedürfnissen:
📋 Fallzusammenfassung
| Fallbezeichnung | Fitch, Even, Tabin and Flannery, LLP v. Tammy E. Dorsey, James R. Balman, and Prenatal-Hope, Inc. |
| Fallnummer | No. 1:25-cv-03141 |
| Gericht | Northern District of Illinois, Chief Judge Sharon Johnson Coleman |
| Dauer | March 25, 2025 – February 23, 2026 335 days |
| Ergebnis | Defendant Win — No Damages to Plaintiff |
| Streitige Patente | |
| Beschuldigte Produkte | Apparatus and method for determining physiological parameters of an infant in utero |
Fallübersicht
Die Parteien
⚖️ Kläger
A prominent Chicago-based intellectual property law firm, acting as plaintiff, signaling a direct IP ownership or enforcement interest.
🛡️ Beklagter
The accused parties in this dispute, with Prenatal-Hope, Inc. likely operating in the prenatal diagnostics or monitoring space.
Streitige Patente
This case centered on U.S. Patent No. US11622705B2, covering an apparatus and method for determining physiological parameters of an infant in utero — a critical technology in the growing market for non-invasive fetal health assessment.
- • US11622705B2 — Apparatus and method for determining physiological parameters of an infant in utero
Designing a prenatal monitoring device?
Check if your technology might infringe this or related patents before launch.
Das Urteil und die rechtliche Analyse
Ergebnis
The court entered a verdict in favor of defendants Tammy E. Dorsey, James R. Balman, and Prenatal-Hope, Inc., and against plaintiff Fitch, Even, Tabin and Flannery, LLP. No damages award to plaintiff was recorded, making this a significant defendant-favorable outcome in medical device patent litigation.
Wichtige rechtliche Fragen
While the specific legal reasoning is undisclosed, a defendant-favorable outcome in a patent infringement action can arise from several pathways: a finding of non-infringement, successful challenges to patent invalidity (e.g., due to obviousness or anticipation), or a claim construction adverse to the plaintiff’s assertions. For medical device method patents, the precise scope of functional claim language often proves dispositive.
Freedom to Operate (FTO) Analysis in Prenatal Monitoring
This case highlights critical IP risks in the rapidly evolving prenatal monitoring space. Choose your next step:
📋 Die Auswirkungen dieses Falls verstehen
Informieren Sie sich über die spezifischen Risiken und Auswirkungen dieses Rechtsstreits.
- View all 65 related patents in this technology space
- See which companies are most active in prenatal monitoring IP
- Understand claim construction patterns for physiological measurement
🔍 Das Risiko meines Produkts überprüfen
Führen Sie eine umfassende FTO-Analyse für Ihre eigene Technologie oder Ihr eigenes Produkt durch.
- Geben Sie Ihre Produktbeschreibung oder technischen Merkmale ein.
- KI identifiziert potenziell blockierende Patente
- Erhalten Sie einen umsetzbaren Risikobewertungsbericht
Hochrisikogebiet
In-utero physiological monitoring methods
65 Related Patents
In prenatal health tech space
Design-Around-Optionen
Verfügbar für die meisten Auslegungsfälle
✅ Wichtigste Erkenntnisse
Defendant prevailed in a medical device method patent (US11622705B2) infringement action in N.D. Illinois within 335 days, suggesting a potentially early dispositive resolution.
Verwandte Rechtsprechung suchen →Claim construction for physiological monitoring method claims remains a critical battleground, impacting both infringement and validity.
Präzedenzfälle erkunden →Häufig gestellte Fragen
The case involved U.S. Patent No. US11622705B2 (Application No. US17/555256), covering an apparatus and method for determining physiological parameters of an infant in utero.
The Northern District of Illinois ruled in favor of defendants Tammy E. Dorsey, James R. Balman, and Prenatal-Hope, Inc., and against plaintiff Fitch, Even, Tabin and Flannery, LLP in this infringement action.
The outcome may embolden defendants in similar cases to mount stronger invalidity and non-infringement defenses, and signals that courts will rigorously apply claim construction standards to physiological monitoring method patents.
The case was resolved within approximately 335 days from filing to closure, which is significantly faster than the national median for patent litigation at the district court level, typically exceeding 18-24 months.
Sind Sie bereit, Ihre Patentstrategie zu stärken?
Schließen Sie sich den über 18.000 Fachleuten aus dem Bereich des geistigen Eigentums an, die PatSnap Eureka nutzen, um mit KI-gestützter Präzision Recherchen zum Stand der Technik durchzuführen, Patentanmeldungen zu erstellen und Wettbewerbslandschaften zu analysieren.
Referenzen
- U.S. District Court for the Northern District of Illinois — Case No. 1:25-cv-03141
- U.S. Patent and Trademark Office — Patent Full-Text Database (US11622705B2)
- Cornell Legal Information Institute — 35 U.S.C. § 103 (Obviousness)
- Federal Judiciary CMECF System — Accessing Court Records
- PatSnap — IP Intelligence Solutions for Medical Devices
Dieser Artikel dient ausschließlich zu Informationszwecken und stellt keine Rechtsberatung dar. Alle Angaben zu den Fällen stammen aus öffentlich zugänglichen Gerichtsakten. Informationen zu den Funktionen der Plattform finden Sie auf PatSnap.